Experienced Physician, Author and Executive to Join Senior Leadership TeamCAMBRIDGE, Mass. (November 2, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Harry Kovelman, MD, is joining the Company as its Chief Medical Officer, effective November 2. In this role, Dr. Kovelman will oversee Myomo’s patient advocacy organization, which helps ensure MyoPro patients’ clinical qualification for the brace and pursues insurance coverage. At Myomo, he will work closely with commercial and government payer organizations to continue to increase patient access to the MyoPro product line. Read more.